摘要
背景:轻度(MCI)和主观认知障碍(SCI)是阿尔茨海默病(AD)发病的危险因素。早期正常衰老之间的差异确实是一个挑战。可用的生物标记物需要结合在一起,并且可以是相当具有侵入性和昂贵的。 目的:本研究旨在探讨MCI和SCI与对照组相比可能出现的脑电图改变,分析认知任务是否能突出早期AD的特征。 方法:选择11例MCI、8例SCI和7例健康对照作为对照,年龄和文化程度相匹配。静息状态和心理状态下的神经心理学评估和脑电记录我们完成了任务。采用经典谱测度和非线性参数来表征脑电图。 结果:在认知任务中,α能带功率降低主要发生在SCI和CS的额叶区,扩散到脑梗死的各个区域,并且在sci com中发现脑电复杂度降低。减少到控制。在一次自由回忆任务(涉及额叶区域)中,α波段功率衰减仅限于SCI中的额叶区域,这表明mci患者可以通过以下方式来弥补编码缺陷。激活不同的大脑网络来完成同样的任务。此外,脑电复杂度降低-已经在SCI中发现-可能是AD早期的一个特征。 结论:本研究提请注意非线性方法在脑电分析中的重要性,以及认知任务在认知早期阶段突出脑电图改变方面的潜在作用。E损害;因此,EEG可能对痴呆的诊断产生实际影响。
关键词: 轻度认知障碍(MCI)、主观认知功能障碍(SCI)、早期阿尔茨海默病(AD)、记忆任务、非线性脑电图分析、脑电信号复杂性。
Current Alzheimer Research
Title:Memorization Test and Resting State EEG Components in Mild and Subjective Cognitive Impairment
Volume: 15 Issue: 9
关键词: 轻度认知障碍(MCI)、主观认知功能障碍(SCI)、早期阿尔茨海默病(AD)、记忆任务、非线性脑电图分析、脑电信号复杂性。
摘要: Background: Mild (MCI) and Subjective Cognitive Impairment (SCI) are conditions at risk of developing Alzheimer’s disease (AD). Differential between normal aging at early stages can be really challenging; available biomarkers need to be combined and can be quite invasive and expensive.
Objective: The aim of this pilot study is to examine possible EEG alterations in MCI and SCI compared to controls, analyzing if a cognitive task could highlight early AD hallmarks.
Method: We recruited 11 MCI, 8 SCI and 7 healthy subjects as controls (CS), all matched for age and education. Neuropsychological assessment and EEG recording, at resting state and during a mental memory task, were performed. Classical spectral measures and nonlinear parameters were used to characterize EEGs.
Results: During cognitive task, α-band power reduction was found predominantly in frontal regions in SCI and CS, diffused to all regions in MCI; moreover, decreased EEG complexity was found in SCI compared to controls. The α -band power attenuation restricted to frontal regions in SCI during a free recall task (involving frontal areas), suggests that MCI patients compensate for encoding deficit by activating different brain networks to perform the same task. Furthermore, EEG complexity reduction - that has been found already in SCI - could be a possible early hallmark of AD.
Conclusion: This study draws attention on the importance of nonlinear approach in EEG analysis and the potential role of cognitive task in highlighting EEG alterations at very early stages of cognitive impairment; EEG could therefore have a practical impact on dementia diagnosis.
Export Options
About this article
Cite this article as:
Memorization Test and Resting State EEG Components in Mild and Subjective Cognitive Impairment, Current Alzheimer Research 2018; 15 (9) . https://dx.doi.org/10.2174/1567205015666180427114520
DOI https://dx.doi.org/10.2174/1567205015666180427114520 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Multitarget Cannabinoids as Novel Strategy for Alzheimer Disease
Current Alzheimer Research Combination of P300 and CSF β-Amyloid(1-42) Assays May Provide a Potential Tool in the Early Diagnosis of Alzheimers Disease
Current Alzheimer Research Elucidating the Risk Factors for Progression from Amyloid-Negative Amnestic Mild Cognitive Impairment to Dementia
Current Alzheimer Research Liver X Receptor-Mediated Gene Regulation and Cholesterol Homeostasis in Brain: Relevance to Alzheimers Disease Therapeutics
Current Alzheimer Research Alzhemed: A Potential Treatment for Alzheimers Disease
Current Alzheimer Research Diabetes Type 4: A Paradigm Shift in the Understanding of Glaucoma, the Brain Specific Diabetes and the Candidature of Insulin as a Therapeutic Agent
Current Molecular Medicine Preface [Hot Topic: Advances in the Four Pillars of Alzheimer Disease Research: Pathobiology, Genetics, Diagnosis, and Treatment (Debomoy K. Lahiri)]
Current Alzheimer Research Synthetic and Medicinal Prospective of Structurally Modified Curcumins
Current Topics in Medicinal Chemistry Discovering New Treatments for Alzheimer's Disease by Repurposing Approved Medications
Current Topics in Medicinal Chemistry Intracranial MR Dynamics in Clinically Diagnosed Alzheimers Disease: The Emerging Concept of “Pulse Wave Encephalopathy”
Current Alzheimer Research Recent Aspects of Osmotic Pump Systems: Functionalization, Clinical use and Advanced Imaging Technology
Current Drug Metabolism Insight into the Role of Photoreception and Light Intervention for Sleep and Neuropsychiatric Behaviour in the Elderly
Current Alzheimer Research Acetylcholinesterase Imaging: Its Use in Therapy Evaluation and Drug Design
Current Pharmaceutical Design Transendothelial Migration of Monocytes: The Underlying Molecular Mechanisms and Consequences of HIV-1 Infection
Current HIV Research Patent Selections:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Modulation of Ischemic Brain Injury and Neuroinflammation by Adenosine A2A Receptors
Current Pharmaceutical Design Substance P and Alzheimer’s Disease: Emerging Novel Roles
Current Alzheimer Research The Contribution of Cerebral Vascular Neuropathology to Mild Stage of Alzheimer’s Dementia Using the NACC Database
Current Alzheimer Research Capacity Building in Genomics Medicine and Molecular Diagnostics: The Case of Sri Lanka
Current Pharmacogenomics and Personalized Medicine Endocannabinoid System in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued)